Trial
NCT01842282
Amlexanox for Type 2 Diabetes and Obesity
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Michigan
Collaborators
—
Condition
Diabetes Mellitus Type 2
Intervention
Amlexanox
Why stopped
Due to limited funding, trial was suspended, intending to restart with additional funds; then preliminary results were obtained, and research moved on to placebo controlled trial. Results for both have been published.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-05-07